Delivery Order SPE2DB22D3016-SPE2DB24FAMS4
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $14,427.24 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide GAMUNEX-C 40 gram/400 ML vials. The contract has a completion date of March 26, 2024 and was awarded on March 5, 2024. AmerisourceBergen Drug Corp is the prime contractor and has an existing indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product GAMUNEX-C 20 GRAM/200 ML VIAL 200ML. The $9,530 contract has an ultimate completion date of April 2, 2024. AmerisourceBergen Drug Corp is the prime contractor and does not have any major subcontractors listed. This delivery order is part of a larger indefinite delivery contract (IDC) with a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of GAMUNEX-C 20 gram/200 ml vials. The contract has a ceiling value of $2,382.50 and a performance period through April 16, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $19,060.00 contract is for the delivery of the pharmaceutical product GAMUNEX-C 20 GRAM/200 ML VIAL 200ML to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds a $999,999,999.00 indefinite delivery contract...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $14,427.24 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4564767201 GAMUNEX-C 40 GRAM/400 ML VIAL 400ML, a medical product, with a performance period ending on June 24, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $14,295.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide GAMUNEX-C 20 GRAM/200 ML VIAL 200ML pharmaceuticals. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
- The U.S. Department of Defense (DOD) Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order contract valued at $28,854.48 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution services company. The delivery order is for the product GAMUNEX-C 40 GRAM/400 ML VIAL 400ML and has a period of performance through April 1, 2024. This award is part of a larger $999,999,999.00 indefinite delivery contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4563603774 - GAMUNEX-C 5 GRAM/50 ML VIAL 50ML. The $12,207.37 contract has a completion date of March 1, 2024 and was awarded on February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under a larger $999,999,999.00 indefinite delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product GAMUNEX-C 40 GRAM/400 ML VIAL 400ML. The contract is a firm fixed price award with a potential value of $48,090.80 and a completion date of March 28, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $9,722.10 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of 4,564,743,440 units of the pharmaceutical product GAMUNEX-C 10 GRAM/100 ML VIAL 100ML, with a completion date of June 20, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which allows the...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FAMS4Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of GAMUNEX-C 20 GRAM/200 ML VIAL 200ML pharmaceutical products. This $16,397.85 contract has a completion date of March 12, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) the company holds with DLA that has a potential value of up to $999,999,999.00 and runs through December 31, 2025. This IDC serves as the primary vehicle for AmerisourceBergen to provide pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this particular delivery order contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.4k | 2/20/24 |